SCHEMBL29700464

SCHEMBL29700464

CP(C)(=O)c1cccc(C(=O)O)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA6 P23280 1/20 0.50
CA9 Q16790 1/20 0.50
HSD17B10 Q99714 3/20 0.47
HPGD P15428 2/20 0.47
KMO O15229 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
UNG P13051 1/20 0.46
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
DAO P14920 1/20 0.44
TSHR P16473 1/20 0.44
NAPRT Q6XQN6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26185623 1.00 CA12 (0.50) CA12CA1CA2CA6CA9
SCHEMBL11653117 0.86 CA12 (0.48) CA12CA1CA2CA6CA9
SCHEMBL29503148 0.82 PARP1 (0.55) HSD17B10MEN1KMT2AL3MBTL1TSHR
SCHEMBL563489 0.82 CA2 (0.52) CA12CA1CA2CA6CA9
SCHEMBL562694 0.82 CA2 (0.54) CA12CA1CA2CA6CA9
SCHEMBL30223402 0.81 HDAC8 (0.59) HPGDMEN1KMT2AKDM4EALDH1A1
SCHEMBL30223420 0.81 HDAC8 (0.59) HPGDMEN1KMT2AKDM4EALDH1A1
SCHEMBL15177798 0.80 KMO (0.57) CA12CA1CA2CA6CA9
SCHEMBL24478812 0.79 RAB9A (0.53) CA12CA1CA2CA9HPGD
SCHEMBL31317830 0.79 RAB9A (0.53) CA12CA1CA2CA9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025011633-A1 ANTAGONIST OF MAS-RELATED G PROTEIN-COUPLED RECEPTOR X2 AND USE THEREOF 北京普祺医药科技股份有限公司 2025-01-16 WO disclosed
EP-4251615-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2023-10-04 EP disclosed
WO-2022112188-A1 SPIRO[3.3]HEPTANE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2022-06-02 WO disclosed